Oral Solid Dosage Pharmaceutical Market Landscape Dominated By Immediate Drug Release Mechanism: Fact.MR Study

Fact.MR – A Market Research and Competitive Intelligence Provider: The global oral solid dosage pharmaceutical market is set to experience robust growth at 6.4% CAGR and cross a market valuation of US$ 1 trillion by the end of 2032.

Germany Accounted For 19.9% Share In The Europe Oral Solid Dosage Pharmaceutical Market In 2021

“Increasing prevalence of chronic diseases and strategic collaborations among key market players are driving the sales of oral solid dosage pharmaceuticals,” says a Fact.MR analyst.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global oral solid dosage pharmaceutical market is set to experience robust growth at 6.4% CAGR and cross a market valuation of US$ 1 trillion by the end of 2032.

Revenue from the sales of oral solid dosage pharmaceuticals accounted for 23.8% share of the global pharmaceutical drug delivery market in 2021.

Rise of usability and patient compliance is also a key aspect driving global demand for oral solid dosage medications and this is a key concern for drug producers. Modified release (MR) oral solid dosage solutions are experiencing a sharp increase in demand due to growing patient-centric drug demand.

For more insights into the Market, Get A Sample of this Report!


Key Takeaways from Market Study

  • By dosage form, tablets held the largest market share of 53.1% in 2021.
  • By drug release mechanism, immediate-release held the largest market share of 57.9% at the end of 2021.
  • By distribution channel, hospital pharmacies accounted for the largest market share of 33.5% in 2021.
  • North America held the largest share of 43.8% in the global oral solid dosage pharmaceutical market in 2021.

Demand growth for global oral solid dosage pharmaceuticals is being driven by various factors such as higher accuracy, easy to transport, and inherently being more stable than other dosage forms such as liquid. Moreover, the shelf life of oral solid dosage drugs is much more than any other form of dosage due to higher product stability. In addition, the past few years have seen several oral solid dosage drug approvals.

  • On April 5, 2022, the FDA gave accelerated approval to Novartis Pharmaceuticals’ alpelisib for adult and pediatric patients with severe symptoms of PIK3CA-related overgrowth spectrum (PROS) who require systemic therapy.
  • On March 11, 2022, AstraZeneca’s olaparib received FDA approval for the treatment of deleterious germline BRCA-mutated (gBRCAm) human epidermal growth factor receptor 2 (HER2)-negative with a high risk of early breast cancer in adults.

For Comprehensive Insights Ask An Analyst Here


Competitive Landscape

Gaining FDA approval and actively collaborating with other players that have a strong position and are popular in the market are key strategies of many market players.

  • In January 2022, Eli Lilly and Company collaborated with Entos Pharmaceuticals to improve the development of innovative therapies in multiple neurologic indications.
  • In December 2021, Merck and Ridgeback announced U.S. FDA emergency use authorization for Molnupiravir for providing treatment to adults with mild to moderate risk of COVID-19.

Key market players such as Eli Lilly and Company and Merck are focusing on collaborations for expanding their product offerings and their overall presence in the market.

Manufacturers of oral solid drugs can attain considerable bioavailability by implementing cutting-edge drug delivery technology methods. For instance, tailored drug delivery and dose forms with prolonged release increase the bioavailability of medications and decrease the need for repeated medication administration.

Key Segments in Oral Solid Dosage Pharmaceutical Industry Research

  • By Dosage Form:
    • Tablets
      • Conventional/Immediate Release
      • Modified Release
      • Chewable Tablets
      • Effervescent Tablets
    • Capsules
      • Hard Gelatin Capsules
      • Soft Gelatin Capsules
      • Others
    • Powders & Granules
    • Lozenges & Pastilles
    • Gummies
  • By Drug Release Mechanism:
    • Immediate Release
    • Delayed Release
    • Controlled Release
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Drug Stores
    • Online Pharmacies
    • Hypermarkets / Supermarkets
  • By Region:
    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia
    • Oceania
    • Middle East and Africa (MEA)

Get Customization on this Report for Specific Research Solutions


More Market Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the oral solid dosage pharmaceutical market, presenting historical demand data (2012-2021) and forecast statistics from 2022 to 2032.

The study divulges essential insights on the market based on dosage form (tablets {conventional/immediate release, modified release, chewable tablets, effervescent tablets}, capsules {hard gelatin capsules, soft gelatin capsules, others}, powders & granules, lozenges & pastilles, gummies), drug release mechanism (immediate release, delayed-release, controlled release), and distribution channel (hospital pharmacies, retail pharmacies, drug stores, online pharmacies, hypermarkets/supermarkets), across seven major regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

Fact.MR’s Domain Knowledge on Healthcare

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Prostate Cancer Diagnostics Market - Prostate Cancer Diagnostics Market By Test Type (PSA, PCA3, CTC & Immunohistochemistry Prostate Cancer Diagnostic Test), By End User (Prostate Cancer Diagnostics in Hospitals, Prostate Cancer Diagnostics in Cancer Research Institutes)- Global Market insights 2021 to 2031

Urodynamic Devices Market - Asia-Pacific excluding Japan (APEJ) is estimated to be the fastest expanding market for urodynamic devices over the forecast period. This robust expansion of the market in APEJ can be attributed to unmet patient requirements, rising prevalence of urological diseases, and increasing purchasing power of people in the region.

Gas Chromatography Market - Gas chromatography has been witnessing a rise in adoption among various industrial sectors such as food & beverage, agriculture, oil & gas, and healthcare. GC is also being used in environmental agencies, research organizations, clinical toxicology, and academic institutes.

Amniocentesis Needle Market - Demand for the amniocentesis needles is expected to gain momentum attributed to growing need for removing excessive amniotic fluid from around the baby. Excessive amniotic fluid during pregnancy leads to increasing risks of complication.

NGS Data Analysis Market - NGS Data Analysis Market Report By Service Type (Whole-Genome, Exome, RNA, ChIP Sequencing), By Technique (SBS, SMRT, Ion semiconductor sequencing), By End User (Hospitals, Research Institutes, Pharmaceutical Companies) - Regional Forecast, 2017-2026

Prefilled Syringes Market - Prefilled Syringes Market By Function Type (Single Chambered Prefilled Syringes, Dual/Multi Chambered Prefilled Syringes), By Technology Type (Conventional Prefilled Syringes, Safety Prefilled Syringes), By Distribution Channel, By Material Type - Forecast 2021-2031

Actigraphy Sensors & PSG Devices Market - Fact.MR report provides comprehensive information about recent developments in the competitive environment in the actigraphy sensor and PSG devices market. The actigraphy sensor and PSG devices market is witnessing positive growth with the frontrunners accounting for nearly two-third of the total revenue in the market.

Lithotripsy Devices Market - Lithotripsy Devices Market Analysis by Product Type (Extracorporeal Shock Wave, Intracorporeal, Laser Lithotripsy Devices), by Application (Kidney Stones, Ureteral Stones, Pancreatic Stones), by End User, by Region - Global Insights 2021-2031

Surgical Sutures Market - Surgical Sutures Market Analysis By Product Type (Absorbable & Non-Absorbable Surgical Sutures) By Source (Natural, Synthetic, Coated & Uncoated Surgical Sutures) By Raw Material, By Application and By End-User – Global Market Insights 2021 to 2031

Earwax Removal Aid Market - In the earwax removal aid market, some top manufacturers such as GlaxoSmithKline Plc., Cipla Ltd, Medline Industries, Inc, and Prestige Consumer Healthcare Inc. account for a significant revenue share of ~30.0%, backed by high brand recognition.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000’s trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis.


Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Follow Us: LinkedIn | Twitter